How is Walmart leading the convergence of clinical care and retail? With global scale that allows for everyday low prices in every community, Walmart is innovating both the clinical and lifestyle sides of healthcare. From pharmacy, food, sporting goods, and more, Walmart is creating an ecosystem that is homebase for a healthy lifestyle.
As the world’s biggest private health plan—with 1.4 million associates worldwide —Walmart is also expanding its associate wellbeing program by partnering with Fresh Tri, an innovative app that uses neuroscience to change behavior by offering practical suggestions, combating iterative thinking to meet specific goals.
Filmed at AHIP’s Consumer Experience & Digital Health Forum in Nashville, TN, December 2018.
Softbank Vision Fund is a $100 billion technology-focused fund with an eagle eye on the tech that is poised to disrupt large markets, including healthcare. From hyperscaling to detailed advice on pitching, VP Sakshi Chhabra Mittal goes deep on what they’re looking for from startups, especially those that have closed their Series A and are looking for a B.
Filmed at the Frontiers Health Conference in Berlin, Germany, November 2018.
Anil Sethi had the health tech exit every startup dreams about: a buyout by Apple. Not content to ride that unicorn into the sunset, Anil’s back at it with his new startup Ciitizen, which is another take on better a patient health record. What’s different? Why come back? Tune in for more and this and Anil’s great advice for other health entrepreneurs.
Kurbo just became a wholly owned subsidiary of WW (aka WeightWatchers) with its app that helps kids lose weight. Co-founder Thea Runyan explains how the digital health solution is changing unhealthy lifestyles for teens and kids everywhere and talks about her company’s successful exit to the weight loss giant.
Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.
Think fax machines are the only out-dated tech in healthcare? Sandeep Bansal, CEO of Medic Bleep makes the case that outdated internal phone-based paging systems used by hospitals need to go too. According to Sandeep, the UK’s NHS clocks 1 billion internal phone calls a year, with a full 23% of them solely made just to find the right number for the person they are really trying to call. What works better? Listen in to how Medic Bleep plans to provide a communication system for health system staffs that actually matches the way they work to deliver care.
Filmed at Webit Health in Sofia, Bulgaria, May 2019.
One of Europe’s top health tech startups, Infermedica out of Poland just closed a $3.65M funding round for its suite of tools that help patients figure out the best place to go to get care. It’s a patient-routing / symptom-checker with “AI under the hood” that is delivered via an app, chatbot, and voice application for Alexa. (In fact, they “own” the symptom checker that opens when you ask Alexa to “open symptom checker.”) Piotr Orzechowski talks about the full range of ways Infermedica is engaging patients and how they are scaling up their provider facing products as a result of this influx of funding.
Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.
DNA testing companies like 23andMe and Ancestry
have made DNA testing mainstream, with adoption skyrocketing among consumers.
Meanwhile, health tech startups like Veritas Genetics are starting to push the trend
even further – from genotyping to whole genome sequencing. What’s the
difference? Well, genotyping looks at less than half of 1% of your
genome, while whole genome sequencing looks at over 99% of your genome.
Veritas is betting that consumers are ready for
what’s revealed by looking at more than 6.4 billion letters of DNA and are
promising that the value of that information will only get richer as time goes
on and the science that makes sense of our genome achieves new breakthroughs.
In fact, Veritas is positioning their $999 test
as “a resource for life” and Rodrigo Martinez, their Chief Marketing &
Design Officer who I chat with here, shares a vision for the future that
includes asking Alexa to scan your genome before taking medications or risking
allergic reactions to foods.
This is fascinating proposition for the future
of health (investors are jazzed too, having poured $50M into the company), but
ethical questions abound. How do you make this information useful and
actionable? How do you handle situations where major health issues are reveled?
And what about data privacy? This is about as personal as personal health
information can get. Rodrigo weighs in…
Apparently, podcasts are new, all the rage and minting billionaires every day! So, of course, THCB had to have its own podcast, and here it is: HardCore Health
Now I’ve been doing “podcasts” (otherwise known as audio or video interviews) on THCB since before people actually had iPods (remember those, kids?). But apparently these days any punter can do an interview, call it a podcast and shove it up on Spotify. Hardcore Health is going to be a little bit different…
Hardcore Health will feature multiple guests, topics, and interludes brought to you by many co-hosts starting off with Jessica DaMassa and me. We’ll embed some (familiar) tidbits into the show including: Health in 2 Point 00, THCB Spotlights, and the WTF Health Show as well as some newer segments, including banter sessions between guests & rant sessions from health care experts. This first episode features Brian Kalis, Accenture’s “post” Digital Health expert & Niko Skievaski from Redox, and a little more.
I hope you enjoy our first episode below!
Matthew Holt is the founder and publisher of The Health Care Blog and still writes regularly for the site.
According to Toby Cosgrove, 2019 is “THE YEAR of telehealth.” The former CEO of Cleveland Clinic, who is currently an executive advisor to Google Cloud’s healthcare and life sciences team, proclaimed it as such to CNBC, saying that this year is “THE YEAR” telehealth becomes ubiquitous.
That’s a pretty bold statement – particularly as utilization rates for virtual visits continue to fall short of expectations – so we double-checked this prognostication with Teladoc’s CEO, Jason Gorevic.
Does he think 2019 is going to be telehealth’s
Well, although he’d rather call the space ‘virtual
care’ instead of ‘telehealth’ (maybe this will be the difference maker?), he
confesses he’s pretty much on board with Cosgrove’s assertion that more
consumers than ever will visit virtual exam rooms this year.
How does 2019 become “THE YEAR” of virtual care?
Is this going to be an industry-wide boon, or is Teladoc just banking on its
partnership with CVS and their new family member, Aetna?
Tune in to hear Jason get real about what’s impacting utilization rates, how things are going to change this year, AND whether or not he’s worried about competing with Apple, Google, and Amazon for screen time. (Hint: He’s not.)
Google’s Verily has a $1Billion dollar investment fund and a nearly limitless talent pool of data scientists and engineers at the ready. So, how are they planning to invest in a better future for health?
Luba Greenwood, Strategic Business Development & Corporate Ventures
for Verily told me how the tech giant is thinking about the big data
opportunity in healthcare – and, more importantly, what they see as their role
in helping scale it in unprecedented ways.
So, where should other health tech investors place their bets, then?
Luba’s previous successes investing in digital health and health technology
while at Roche (FlatIron, MySugr, etc.) give her a unique perspective on the
‘state-of-play’ in healthcare investment…but has the game changed now that she’s
in another league at Verily? Listen in to find out.
Filmed at the Together.Health Spring Summit at HIMSS 2019 in Orlando,
Florida, February 2019.
Get a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.